Abstract
We studied possibility of secondary hyperlipidemia correction at a nephrotic syndrome in 68 patients with chronic glomerulonephritis. Research has shown that use immunosupressive pathogenetic therapy in a combination with statins and plasmosorption has advantage before its combination only with lipid reduction preparation or only with plasmosorption. The given method of treatment allows to achieve improvement of lipid exchange indicators and disease remission for shorter terms in comparison with standard therapy.